Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01211366 · ClinicalTrials.gov registry record · NA
Use of Cell Salvage Post-operatively in Infants to Decrease Use of Allogeneic Blood Product Transfusions
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT01211366 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 106 participants.
The verdict
NCT01211366, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Transfusion of washed intra-operative cell salvage post-operatively in the PCICU can be performed safely without increased risk of bleeding or release of inflammatory mediators. This will reduce the need for allogeneic blood products as well as crystalloid and colloid infusions and thus decrease the length of ventilation and intensive care duration for these infants.
Interventions
- OTHER Cell Saver RBCs
- OTHER Conventional volume infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01211366
The ClinicalTrials.gov registry entry for NCT01211366 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cell Saver RBCs is the first listed.
NCT01211366 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01211366 about?
NCT01211366 is a clinical study titled "Use of Cell Salvage Post-operatively in Infants to Decrease Use of Allogeneic Blood Product Transfusions". Transfusion of washed intra-operative cell salvage post-operatively in the PCICU can be performed safely without increased risk of bleeding or release of inflammatory mediators. This will reduce the need for allogeneic blood products as well as crystalloid and colloid infusions and thus decrease the...
What is the current status of trial NCT01211366?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2010-10. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01211366?
The interventions under investigation include: Cell Saver RBCs (OTHER), Conventional volume infusion (OTHER).
Who is sponsoring clinical trial NCT01211366?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.